Imperial College London

Dr Hannah M Cheeseman

Faculty of MedicineDepartment of Infectious Disease

Postdoctoral Researcher & Clinical Trials Laboratory Manager
 
 
 
//

Contact

 

+44 (0)20 7594 2540hannah.cheeseman

 
 
//

Location

 

457 - Shattock GroupNorfolk PlaceSt Mary's Campus

//

Summary

 

Publications

Journals

Moshe M, Daunt A, Flower B, et al., 2021, SARS-CoV-2 lateral flow assays for possible use in national covid-19 seroprevalence surveys (REACT2): diagnostic accuracy study, Bmj: British Medical Journal, ISSN:0959-535X

Tregoning JS, Brown ES, Cheeseman HM, et al., 2020, Vaccines for COVID-19, Clinical and Experimental Immunology, Vol:202, ISSN:0009-9104, Pages:162-192

Flower B, Brown JC, Simmons B, et al., 2020, Clinical and laboratory evaluation of SARS-CoV-2 lateral flow assays for use in a national COVID-19 sero-prevalence survey, Thorax, Vol:75, ISSN:0040-6376, Pages:1082-1088

Abraham S, Juel HB, Bang P, et al., 2019, Safety and immunogenicity of the chlamydia vaccine candidate CTH522 adjuvanted with CAF01 liposomes or aluminium hydroxide: a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial, Lancet Infectious Diseases, Vol:19, ISSN:1473-3099, Pages:1091-1100

Cheeseman HM, Day S, McFarlane LR, et al., 2018, Combined Skin and Muscle DNA Priming Provides Enhanced Humoral Responses to a Human Immunodeficency Virus Type 1 Clade C Envelope Vaccine, Human Gene Therapy, Vol:29, ISSN:1043-0342, Pages:1011-1028

More Publications